Drug resistance profiles in patients attending to an HIV clinic in Quito: a pilot study
HIV/AIDS is one of the most important chronic infectious diseases. Although ART therapies decreased morbidity and mortality considerably, new cases continue to appear. HIV-1 drug resistance is one of the most important problems that delay 95-95-95 goals. The presence of drug resistance mutations in...
Saved in:
Main Authors: | Paulina Quirola Amores, Pablo Espinosa, Nelson Cevallos, Enrique Teran |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad San Francisco de Quito USFQ
2025-07-01
|
Series: | ACI Avances en Ciencias e Ingenierías |
Subjects: | |
Online Access: | https://revistas.usfq.edu.ec/index.php/avances/article/view/3298 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
by: A. V. Kravchenko, et al.
Published: (2018-07-01) -
Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients
by: A. A. Kirichenko, et al.
Published: (2021-01-01) -
The Impact of Race, Education, Economic Vulnerability, and Stigma on Viral Load Detectability Among People Living with HIV in Brazil
by: Brandelli Costa A, et al.
Published: (2025-08-01) -
Bridging Palliative Care and HIV/AIDS: A Call for Integrated Approaches
by: Rudi Putranto
Published: (2025-07-01) -
HIV / AIDS
Published: (2000)